Category: Health Autonomy

Rep. Jason Chaffetz (R-UT), a noted champion of natural supplements, has announced he will not seek re-election in 2018. The announcement came last week. He may even retire before his term ends. As one of natural health’s foremost advocates in Congress, we are sad to see him go. Rep. Chaffetz was a staunch supporter of… Continue reading Supplement Advocates Are Losing a Champion in Congress

The FDA is likely to move against numerous natural, compounded medicines. Action Alert! The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on what supplements and drugs can be individually formulated for patients—many of whom have very specific needs that can only be met through these alternative formulations. The next meeting of the PCAC has… Continue reading Even More Natural Medicines Are Now at Risk

While the national movement that swept Donald Trump into office leaned heavily on a “Drain the Swamp” slogan, FDA officials are filling the swamp with more murky water and many of them are leaving the agency en masse to work at a Big Pharma consulting/lobbying firm. Greenleaf Health, which may not have been on your… Continue reading Still Think the FDA Looks Out for Consumers?

After selling out to Big Pharma, 23andMe went from being a pariah with the FDA to being a darling. Recently, the FDA approved 23andMe’s direct-to-consumer genetic tests for ten conditions, including Parkinson’s disease, Alzheimer’s, and celiac disease. Consumers send 23andMe a saliva sample, and the company sends back genetic data analyzing the disease risk of… Continue reading FDA Loosens Reins on 23andMe Gene Tests

Get a second opinion, and you’ll get confused. That could be the new motto for a healthcare industry characterized by dueling diagnoses. According to a new study by the Mayo Clinic, nine out of ten people who seek a second opinion after receiving an initial diagnosis from a doctor get either a somewhat different or… Continue reading Doctors Disagree…88% of the Time

Or just legalize an alternative? Following a politically disastrous failure to repeal and replace Obamacare earlier this year, reports suggest that House Republicans are “close” to a plan that might pass. We’ll report on this as soon as details become available. One thing, however, remains abundantly clear: consumer control must be central to any healthcare… Continue reading Repeal/Replace O-Care?

The opioid epidemic is wreaking havoc—destroying lives and families—and the only true solution is through natural alternatives. Increasingly, people are waking up to this fact. More than 30,000 Americans each year die of opioid overdoses, half of which involve a prescription painkiller, according to the Centers for Disease Control and Prevention (CDC). The crisis of… Continue reading Momentum: Natural Solutions Increasingly Seen as Solution to Opioid Crisis

President Trump’s pick for FDA commissioner, Dr. Scott Gottlieb, faced Congress recently. As you know, this nomination could prove pivotal for the future of natural health. It is important for our readers to be aware of his background. Dr. Gottlieb is currently a practicing physician at Stamford Hospital in Connecticut, and a resident fellow at… Continue reading Scott Gottlieb Appointed by Trump Administration to Head FDA

Those taking aspirin every day to thin blood and reduce stroke risk, take heed. Researchers have found that, compared to those taking warfarin for atrial fibrillation (irregular and fast beating of the heart that can lead to stroke), patients taking aspirin were 1.9 times more likely to suffer a heart attack. The same paper found… Continue reading An Aspirin a Day…Doubles Heart Attack Risk?

Promising studies are lacking follow-up and funding. The problem? The solutions are too cheap! One such potential treatment is an experimental, synthetic cancer drug—DCA (dichloroacetate)—which has, in the early stages of clinical trials, demonstrated effectiveness at fighting cancer. The drug seems to exhibit antitumor effects against several forms of cancer, including brain, cervical, prostate, breast,… Continue reading Cancer Control Within Reach? Only If It’s Profitable!